Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × 4-amino-4'-hydroxylaminodiphenylsulfone × 30 days × Clear all

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

pembrolizumab 27 Cyclophosphamide 17 Nivolumab 14 Paclitaxel 11 Cisplatin 11 Gemcitabine 10 Carboplatin 10 Radiotherapy 9 Surveys and Questionnaires 8 regorafenib 7 fludarabine 7 Standard of Care 7 Doxorubicin 7 Cetuximab 7 Blood Specimen Collection 7 olaparib 6 Rituximab 6 Radiotherapy, Intensity-Modulated 6 Oxaliplatin 6 Ipilimumab 6 Fulvestrant 6 Docetaxel 6 Capecitabine 6 Androgen Antagonists 6 durvalumab 5 atezolizumab 5 Radiosurgery 5 Prednisone 5 Magnetic Resonance Spectroscopy 5 Leucovorin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04308356 2026-03-11

ESOP

Assistance Publique - Hôpitaux de Paris

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡